These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2145256)

  • 41. In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum.
    Arrieta AC; Stutman HR; Akaniro JC; Vargas OM
    Diagn Microbiol Infect Dis; 1992; 15(3):247-51. PubMed ID: 1533825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The post-antibiotic effect of teicoplanin: monotherapy and combination studies.
    Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():1-7. PubMed ID: 1829074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H; Rivière M; Darbas H; Boyer G
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R; Barre J; Varon E
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.
    Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D;
    J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates.
    Carsenti-Etesse H; Durant J; Entenza J; Mondain V; Pradier C; Bernard E; Dellamonica P
    Antimicrob Agents Chemother; 1993 Apr; 37(4):921-3. PubMed ID: 8494393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiology of methicillin-resistance among Staphylococci strains isolated in risk units and effects of the vancomycin on the expression of methicillin-resistance].
    Roveta S; Tonoli E; Marchese A; Schito GC
    Infez Med; 2001 Jun; 9(2):82-9. PubMed ID: 12698020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Bush LM; Boscia JA; Wendeler M; Pitsakis PG; Kaye D
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1198-200. PubMed ID: 2552901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials].
    Giglio MS; Farías O; Lafourcade M; Pinto ME
    Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin.
    Fu KP; Foleno B; Rosenthale ME
    Diagn Microbiol Infect Dis; 1992; 15(4):375-8. PubMed ID: 1611855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
    Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
    Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.